112 related articles for article (PubMed ID: 12650030)
1. [Clinical importance of semi-quantitative monitoring of lymphomas using the comparative polymerase chain reaction].
Slavícková A; Ivánek R; Cerný J; Sálková J; Trnĕný M
Cas Lek Cesk; 2002 Nov; 141(23):735-8. PubMed ID: 12650030
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of residual disease in non-Hodgkin's lymphomas by quantitative PCR (preliminary report).
Slavícková A; Ullmannová V; Benesová E; Klener P
Folia Biol (Praha); 1999; 45(5):179-83. PubMed ID: 10730886
[TBL] [Abstract][Full Text] [Related]
3. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
[TBL] [Abstract][Full Text] [Related]
5. [Molecular diagnosis in hematopoietic malignancy].
Hoshino A; Funato T; Sasaki T
Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
[TBL] [Abstract][Full Text] [Related]
6. [Detection and significance of chromosome abnormalities in patients with malignant non-Hodgkin's lymphoma using the polymerase chain reaction].
Janda J; Benesová E; Slavícková A; Klener P
Cas Lek Cesk; 1999 Jan; 138(2):47-51. PubMed ID: 10376403
[TBL] [Abstract][Full Text] [Related]
7. [Semiquantitative monitoring of molecular markers in non-Hodgkin's lymphoma].
Slavícková A; Benesová E; Bradová V; Ullmanová V
Cas Lek Cesk; 1997 Apr; 136(7):221-5. PubMed ID: 9221198
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
9. Optimized multiplex IgH/ras PCR: a tool for quantitative monitoring of B-lymphoproliferative disorders.
Slavícková A; Ullmannová V; Klener P
Biotechniques; 2000 Apr; 28(4):716-8, 720-1. PubMed ID: 10769750
[TBL] [Abstract][Full Text] [Related]
10. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma.
Kang YH; Park CJ; Seo EJ; Huh J; Kim SB; Kang YK; Chi HS
Cancer; 2002 Jun; 94(12):3073-82. PubMed ID: 12115337
[TBL] [Abstract][Full Text] [Related]
12. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
[TBL] [Abstract][Full Text] [Related]
13. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.
González M; González D; López-Pérez R; García-Sanz R; Chillón MC; Balanzategui A; Mateos MV; Alaejos I; Langerak AW; Orfão A; Van Dongen JJ; San Miguel JF
Haematologica; 1999 Sep; 84(9):779-84. PubMed ID: 10477449
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative PCR in the diagnosis of Leishmania].
Mortarino M; Franceschi A; Mancianti F; Bazzocchi C; Genchi C; Bandi C
Parassitologia; 2004 Jun; 46(1-2):163-7. PubMed ID: 15305709
[TBL] [Abstract][Full Text] [Related]
15. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
16. [Detection of minimal disease in bone marrow from non-Hodgkin's lymphoma and its clinical significance].
Zhang W; Zhu P; Yu S
Zhonghua Yi Xue Za Zhi; 1996 Mar; 76(3):207-10. PubMed ID: 8758431
[TBL] [Abstract][Full Text] [Related]
17. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
Jahnke K; Hummel M; Korfel A; Burmeister T; Kiewe P; Klasen HA; Müller HH; Stein H; Thiel E
J Clin Oncol; 2006 Oct; 24(29):4754-7. PubMed ID: 16966685
[TBL] [Abstract][Full Text] [Related]
18. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
[TBL] [Abstract][Full Text] [Related]
19. Polymerase chain reaction detection of rearranged immunoglobulin heavy chain DNA in plasma samples is useful in the diagnosis of B-cell lymphoma.
Tohda S; Murakami N; Nara N
Int J Hematol; 2000 Jul; 72(1):74-8. PubMed ID: 10979213
[TBL] [Abstract][Full Text] [Related]
20. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]